| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/10/2002 | US6448233 System for dispensing benzoyl peroxide and macrolide or aminoglycoside antibiotic for treatment of acne wherein each is present in a high concentration and dispensing causes mixing to achieve desired concentration for topical use |
| 09/10/2002 | US6448093 Solubilization of hyaluronic acid in aqueous solution of electrolyte and acid; solubilization of polar substancec (i.e. a plasmid) in mixture; acidification; dialyzing said mixture to reduce an ionic concentration past point of collapse |
| 09/10/2002 | US6447820 Pharmaceutical composition for the prevention and treatment of scar tissue |
| 09/10/2002 | US6447815 Heated alcohol extraction of herbs |
| 09/10/2002 | US6447814 Plant extracts used for prevention of cardiovascular disorders, obtained by solvent extraction, heating, filtration and condensation, then encapsulation to form particles; side effect reduction |
| 09/10/2002 | US6447807 Coating and casing powders in acid resistant hydrophobic polymers to produce moisture proof, durable and workable particles; drug delivery; dietetics |
| 09/10/2002 | US6447806 Water insoluble cyclosporin colloids having charged phosphatides on the surface as stabilizers; drug delivery |
| 09/10/2002 | US6447803 Containing addition polymer |
| 09/10/2002 | US6447801 Comprising liposomes having phosphotide membranes enclosing water soluble anthelmintic drugs used as insect repellants and for prevention of schistosomiasis |
| 09/10/2002 | US6447800 Method of loading preformed liposomes using ethanol |
| 09/10/2002 | US6447797 Prevent the adhesion of haemophilus influenzae onto the nasopharyngeal cells of mammals and humans; prophylaxis and treatment of otitis |
| 09/10/2002 | US6447796 Sustained release hydrophobic bioactive PLGA microspheres |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447753 Biodegradable material |
| 09/10/2002 | US6447752 Amorphous porous particles for deep lung delivery |
| 09/10/2002 | US6447751 Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus |
| 09/10/2002 | US6447750 Medicinal aerosol formulation |
| 09/10/2002 | CA2288375C Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 09/10/2002 | CA2260852C Pleasant-tasting aqueous liquid composition of a bitter-tasting drug |
| 09/10/2002 | CA2251586C Electrostatic chucks |
| 09/10/2002 | CA2083766C Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained |
| 09/10/2002 | CA2053933C Nutritional composition comprising hydrolysed soluble fiber |
| 09/10/2002 | CA2046225C Segmented absorbable copolymer |
| 09/08/2002 | CA2380716A1 Dna vaccine using liposome-encapsulated plasmid dna encoding for hemagglutinin protein of influenza virus |
| 09/06/2002 | WO2002069232A2 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | WO2002069198A2 Hla ligand database utilizing predictive algorithms and methods of making and using same |
| 09/06/2002 | WO2002068676A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 09/06/2002 | WO2002068562A2 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use |
| 09/06/2002 | WO2002068561A2 Cubic liquid crystalline phase precursor |
| 09/06/2002 | WO2002068111A1 Process for making microcapsules involving phase inversion |
| 09/06/2002 | WO2002068015A2 Modular infusion device and method |
| 09/06/2002 | WO2002067995A1 Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines |
| 09/06/2002 | WO2002067991A1 Erodible polymers for injection |
| 09/06/2002 | WO2002067990A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | WO2002067989A1 Crystallisation-resistant aqueous growth hormone formulations |
| 09/06/2002 | WO2002067977A1 Eye drops |
| 09/06/2002 | WO2002067972A1 Method of inducing vitreous detachment |
| 09/06/2002 | WO2002067971A2 Use of endostatin in the treatment of ocular neovascularization |
| 09/06/2002 | WO2002067970A1 TRYPTOPHANYL-tRNA SYNTHETASE DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 09/06/2002 | WO2002067966A1 Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer |
| 09/06/2002 | WO2002067961A2 Therapeutic uses of herbal compositions |
| 09/06/2002 | WO2002067960A1 Herbal compositions useful as chemopreventive and therapeutic agents |
| 09/06/2002 | WO2002067955A2 A process for the manufacture of a herbal composition comprising a matrine |
| 09/06/2002 | WO2002067952A1 Prophylactic teat treatment |
| 09/06/2002 | WO2002067951A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 09/06/2002 | WO2002067943A1 Oral pharmaceutical composition of cefpodoxime proxetil |
| 09/06/2002 | WO2002067935A1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 09/06/2002 | WO2002067917A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | WO2002067916A2 Pharmaceutical salts |
| 09/06/2002 | WO2002067908A1 Novel dendritic polymers and their biomedical uses |
| 09/06/2002 | WO2002067906A1 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 09/06/2002 | WO2002067905A1 A sustained release pharmaceutical formulation |
| 09/06/2002 | WO2002067904A1 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer |
| 09/06/2002 | WO2002067903A2 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 09/06/2002 | WO2002067902A2 Modulation of release from dry powder formulations |
| 09/06/2002 | WO2002067901A1 Fibrate-statin combinations with reduced fed-fasted effects |
| 09/06/2002 | WO2002067900A1 Multi-lamellar emulsion(mle) for stabilizing dermatologically useful ingredients and external base preparations for general skin diseases utilizing the same |
| 09/06/2002 | WO2002067899A1 Injectable water-in-oil emulsions |
| 09/06/2002 | WO2002067898A1 Prolongation of chemical activity of flavorants and therapeutics with cetyl pyridinium chloride |
| 09/06/2002 | WO2002067897A2 In-situ gel formation of pectins |
| 09/06/2002 | WO2002067895A2 Implant dosage form and use thereof for the delivery of a cholesterol lowering agent |
| 09/06/2002 | WO2002067894A2 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
| 09/06/2002 | WO2002067893A2 Pharmaceutical formulation comprising bicalutamide |
| 09/06/2002 | WO2002067890A2 Method and product for skin lightening |
| 09/06/2002 | WO2002067854A2 Manufacture of thyroid hormone tablets having consistent active moiety amounts |
| 09/06/2002 | WO2002067852A2 A controlled release pharmaceutical composition |
| 09/06/2002 | WO2002067846A2 A vaccine composition and method of using the same |
| 09/06/2002 | WO2002067831A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | WO2002067770A2 Implantable device using ultra-nanocrystalline diamond |
| 09/06/2002 | WO2002067761A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 09/06/2002 | WO2002067677A2 Patch for the release of volatile substances to environment |
| 09/06/2002 | WO2002067651A2 Pharmaceutical salts |
| 09/06/2002 | WO2002055059A3 Method for preparing submicron particle suspensions |
| 09/06/2002 | WO2002053092A3 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 09/06/2002 | WO2002047659A3 Preparation of drug particles using evaporation precipitation into aqueous solutions |
| 09/06/2002 | WO2002045691A3 Laboratory scale milling process |
| 09/06/2002 | WO2002043708A3 Magnetic particles for the targeted regional therapy |
| 09/06/2002 | WO2002043659A3 Composition containing statins and calcium for improved cardiovascular health |
| 09/06/2002 | WO2002041765A3 Biodegradable bioadhesive controlled release system of nano-particles for oral care products |
| 09/06/2002 | WO2002040062A3 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/06/2002 | WO2002030264A8 Microchip reservoir devices using wireless transmission of power and data |
| 09/06/2002 | WO2002024185A3 Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| 09/06/2002 | WO2002023995A8 Method of blocking free radical processes which result in media ted pathology without deleterious pro-oxidant side reactions |
| 09/06/2002 | WO2002019985A3 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
| 09/06/2002 | WO2002019972A3 Stabilized ascorbic acid solutions |
| 09/06/2002 | WO2002017885A3 Controlled release formulation of erythromycin or a derivative thereof |
| 09/06/2002 | WO2002005796A3 Use of a spla2 inhibitor for the treatment of sepsis |
| 09/06/2002 | WO2001097637A3 Production of oil encapsulated minerals and vitamins in a glassy matrix |
| 09/06/2002 | WO2001082910A3 Combination of progesterone and mifepristone for cancer therapy |
| 09/06/2002 | WO2001049687A9 Cyclohexene nucleic acids |
| 09/06/2002 | WO2001037814A9 Bilayered buccal tablets comprising nicotine |
| 09/06/2002 | WO2001015553A9 Dietary food supplement containing natural cyclooxygenase inhibitors |
| 09/06/2002 | WO2001012170A3 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 09/06/2002 | WO2001012106A9 Composite shaped bodies and methods for their production and use |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | WO2001002024A9 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 09/06/2002 | CA2725635A1 Pharmaceutical salts of 6-dimethylaminomethyl-1-phenylcyclohexane compounds |
| 09/06/2002 | CA2440740A1 Hla ligand database utilizing predictive algorithms and methods of making and using same |